These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

248 related items for PubMed ID: 32891346

  • 1. Failure to administer multimodality therapy leads to sub-optimal outcomes for patients with node-positive biliary tract cancers in the United States.
    Sheka AC, Altman A, Marmor S, Hui JYC, Denbo JW, Ankeny JS, Jensen EH.
    Surg Oncol; 2020 Sep; 34():298-303. PubMed ID: 32891346
    [Abstract] [Full Text] [Related]

  • 2. The role of surgery and adjuvant therapy in lymph node-positive cancers of the gallbladder and intrahepatic bile ducts.
    Tran Cao HS, Zhang Q, Sada YH, Chai C, Curley SA, Massarweh NN.
    Cancer; 2018 Jan 01; 124(1):74-83. PubMed ID: 28841223
    [Abstract] [Full Text] [Related]

  • 3. Outcome of adjuvant therapy in biliary tract cancers.
    McNamara MG, Walter T, Horgan AM, Amir E, Cleary S, McKeever EL, Min T, Wallace E, Hedley D, Krzyzanowska M, Moore M, Gallinger S, Greig P, Serra S, Dawson LA, Knox JJ.
    Am J Clin Oncol; 2015 Aug 01; 38(4):382-7. PubMed ID: 24572429
    [Abstract] [Full Text] [Related]

  • 4. Second-line Chemotherapy Prolongs Survival in Real World Patients With Advanced Biliary Tract and Gallbladder Cancers: A Multicenter Retrospective Population-based Cohort Study.
    Zaidi A, Chandna N, Narasimhan G, Moser M, Haider K, Chalchal H, Shaw J, Ahmed S.
    Am J Clin Oncol; 2021 Mar 01; 44(3):93-98. PubMed ID: 33350678
    [Abstract] [Full Text] [Related]

  • 5. The addition of chemoradiation to adjuvant chemotherapy is associated with improved survival in lymph node-positive gastric cancer.
    Altman AM, Sheka AC, Marmor S, Lou E, Reynolds M, Hui JYC, Tuttle TM, Jensen EH, Denbo JW.
    Surg Oncol; 2020 Sep 01; 34():134-139. PubMed ID: 32891318
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. A Propensity Score Analysis of Chemotherapy Use in Patients With Resectable Gallbladder Cancer.
    Ozer M, Goksu SY, Sanford NN, Porembka M, Khurshid H, Ahn C, Maxwell MC, Beg MS, Kazmi SM.
    JAMA Netw Open; 2022 Feb 01; 5(2):e2146912. PubMed ID: 35171262
    [Abstract] [Full Text] [Related]

  • 9. Therapeutic relevance of targeted sequencing in management of patients with advanced biliary tract cancer: DNA damage repair gene mutations as a predictive biomarker.
    Chae H, Kim D, Yoo C, Kim KP, Jeong JH, Chang HM, Lee SS, Park DH, Song TJ, Hwang S, Kim KH, Song GW, Ahn CS, Lee JH, Hwang DW, Kim SC, Jang SJ, Hong SM, Kim TW, Ryoo BY.
    Eur J Cancer; 2019 Oct 01; 120():31-39. PubMed ID: 31476489
    [Abstract] [Full Text] [Related]

  • 10. Surgical treatment and adjuvant chemotherapy for patients with biliary tract cancer: single institution experience of 100 patients.
    Harada N, Shirabe K, Yoshizumi T, Ikegami T, Uchiyama H, Soejima Y, Yamashita Y, Saeki H, Oki E, Kawanaka H, Morita M, Ikeda T, Matsuura H, Okadome K, Maehara Y.
    Fukuoka Igaku Zasshi; 2013 Dec 01; 104(12):539-48. PubMed ID: 24693682
    [Abstract] [Full Text] [Related]

  • 11. Surgical Resection Alone is Associated With Higher Long-Term Survival Than Multiagent Chemotherapy Alone for Patients With Localized Biliary Tract Cancers.
    Elshami M, Ammori JB, Hardacre JM, Selfridge JE, Bajor D, Mohamed A, Chakrabarti S, Mahipal A, Winter JM, Ocuin LM.
    J Surg Res; 2024 Mar 01; 295():705-716. PubMed ID: 38141457
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Prognostic factors and adjuvant treatments for surgically treated cancers of the biliary tract: a multicentre study of the Anatolian Society of Medical Oncology (ASMO).
    Unal OU, Oztop I, Kos T, Assoc, Turan N, Kucukoner M, Helvaci K, Berk V, Sevinc A, Yildiz R, Cinkir Hy, Tonyali O, Demirci U, Aktas B, Balakan O, Yilmaz AU.
    Asian Pac J Cancer Prev; 2014 Mar 01; 15(22):9687-92. PubMed ID: 25520089
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Neoadjuvant vs. adjuvant chemotherapy for cholangiocarcinoma: A propensity score matched analysis.
    Yadav S, Xie H, Bin-Riaz I, Sharma P, Durani U, Goyal G, Borah B, Borad MJ, Smoot RL, Roberts LR, Go RS, McWilliams RR, Mahipal A.
    Eur J Surg Oncol; 2019 Aug 01; 45(8):1432-1438. PubMed ID: 30914290
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The efficiency and regimen choice of adjuvant chemotherapy in biliary tract cancer: A STROBE-compliant retrospective cohort study.
    Yin L, Xu Q, Li J, Wei Q, Ying J.
    Medicine (Baltimore); 2018 Dec 01; 97(50):e13570. PubMed ID: 30558021
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.